nodes	percent_of_prediction	percent_of_DWPC	metapath
Fidaxomicin—ABCB1—Mitomycin—urinary bladder cancer	0.423	0.505	CbGbCtD
Fidaxomicin—ABCB1—Gemcitabine—urinary bladder cancer	0.122	0.145	CbGbCtD
Fidaxomicin—ABCB1—Cisplatin—urinary bladder cancer	0.0884	0.106	CbGbCtD
Fidaxomicin—ABCB1—Etoposide—urinary bladder cancer	0.0868	0.104	CbGbCtD
Fidaxomicin—ABCB1—Doxorubicin—urinary bladder cancer	0.0592	0.0708	CbGbCtD
Fidaxomicin—ABCB1—Methotrexate—urinary bladder cancer	0.0574	0.0686	CbGbCtD
Fidaxomicin—Megacolon—Methotrexate—urinary bladder cancer	0.00694	0.0424	CcSEcCtD
Fidaxomicin—Metabolic acidosis—Etoposide—urinary bladder cancer	0.00481	0.0294	CcSEcCtD
Fidaxomicin—Hyperglycaemia—Valrubicin—urinary bladder cancer	0.00432	0.0264	CcSEcCtD
Fidaxomicin—Intestinal obstruction—Thiotepa—urinary bladder cancer	0.00388	0.0237	CcSEcCtD
Fidaxomicin—Flatulence—Valrubicin—urinary bladder cancer	0.00329	0.0201	CcSEcCtD
Fidaxomicin—Anaemia—Valrubicin—urinary bladder cancer	0.00309	0.0188	CcSEcCtD
Fidaxomicin—Gastrointestinal pain—Valrubicin—urinary bladder cancer	0.00223	0.0136	CcSEcCtD
Fidaxomicin—Abdominal pain—Valrubicin—urinary bladder cancer	0.00216	0.0132	CcSEcCtD
Fidaxomicin—Anaemia—Mitomycin—urinary bladder cancer	0.00213	0.013	CcSEcCtD
Fidaxomicin—Pruritus—Valrubicin—urinary bladder cancer	0.00193	0.0118	CcSEcCtD
Fidaxomicin—Dizziness—Valrubicin—urinary bladder cancer	0.0018	0.011	CcSEcCtD
Fidaxomicin—Vomiting—Valrubicin—urinary bladder cancer	0.00173	0.0106	CcSEcCtD
Fidaxomicin—Rash—Valrubicin—urinary bladder cancer	0.00172	0.0105	CcSEcCtD
Fidaxomicin—Dermatitis—Valrubicin—urinary bladder cancer	0.00172	0.0105	CcSEcCtD
Fidaxomicin—Headache—Valrubicin—urinary bladder cancer	0.00171	0.0104	CcSEcCtD
Fidaxomicin—Alanine aminotransferase increased—Thiotepa—urinary bladder cancer	0.0017	0.0103	CcSEcCtD
Fidaxomicin—Dyspnoea—Mitomycin—urinary bladder cancer	0.00167	0.0102	CcSEcCtD
Fidaxomicin—Decreased appetite—Mitomycin—urinary bladder cancer	0.00163	0.00996	CcSEcCtD
Fidaxomicin—Nausea—Valrubicin—urinary bladder cancer	0.00162	0.00988	CcSEcCtD
Fidaxomicin—Gastrointestinal haemorrhage—Fluorouracil—urinary bladder cancer	0.00159	0.0097	CcSEcCtD
Fidaxomicin—Gastrointestinal haemorrhage—Cisplatin—urinary bladder cancer	0.00151	0.0092	CcSEcCtD
Fidaxomicin—Hyperglycaemia—Thiotepa—urinary bladder cancer	0.0015	0.00914	CcSEcCtD
Fidaxomicin—Alanine aminotransferase increased—Gemcitabine—urinary bladder cancer	0.00143	0.0087	CcSEcCtD
Fidaxomicin—Hepatobiliary disease—Thiotepa—urinary bladder cancer	0.0014	0.00855	CcSEcCtD
Fidaxomicin—Dysphagia—Fluorouracil—urinary bladder cancer	0.00137	0.00838	CcSEcCtD
Fidaxomicin—Neutropenia—Gemcitabine—urinary bladder cancer	0.00131	0.00797	CcSEcCtD
Fidaxomicin—Hyperglycaemia—Gemcitabine—urinary bladder cancer	0.00126	0.00769	CcSEcCtD
Fidaxomicin—Dizziness—Mitomycin—urinary bladder cancer	0.00124	0.00758	CcSEcCtD
Fidaxomicin—Alanine aminotransferase increased—Etoposide—urinary bladder cancer	0.00122	0.00743	CcSEcCtD
Fidaxomicin—Immune system disorder—Thiotepa—urinary bladder cancer	0.0012	0.00733	CcSEcCtD
Fidaxomicin—Vomiting—Mitomycin—urinary bladder cancer	0.00119	0.00729	CcSEcCtD
Fidaxomicin—Dysphagia—Etoposide—urinary bladder cancer	0.00119	0.00728	CcSEcCtD
Fidaxomicin—Rash—Mitomycin—urinary bladder cancer	0.00118	0.00723	CcSEcCtD
Fidaxomicin—Dermatitis—Mitomycin—urinary bladder cancer	0.00118	0.00722	CcSEcCtD
Fidaxomicin—Hepatobiliary disease—Gemcitabine—urinary bladder cancer	0.00118	0.00719	CcSEcCtD
Fidaxomicin—Headache—Mitomycin—urinary bladder cancer	0.00118	0.00718	CcSEcCtD
Fidaxomicin—Malnutrition—Thiotepa—urinary bladder cancer	0.00116	0.00706	CcSEcCtD
Fidaxomicin—Neutropenia—Etoposide—urinary bladder cancer	0.00112	0.00681	CcSEcCtD
Fidaxomicin—Nausea—Mitomycin—urinary bladder cancer	0.00112	0.00681	CcSEcCtD
Fidaxomicin—Hepatobiliary disease—Cisplatin—urinary bladder cancer	0.0011	0.0067	CcSEcCtD
Fidaxomicin—Anaemia—Thiotepa—urinary bladder cancer	0.00107	0.00653	CcSEcCtD
Fidaxomicin—Immune system disorder—Gemcitabine—urinary bladder cancer	0.00101	0.00617	CcSEcCtD
Fidaxomicin—Hepatobiliary disease—Etoposide—urinary bladder cancer	0.00101	0.00614	CcSEcCtD
Fidaxomicin—Unspecified disorder of skin and subcutaneous tissue—Thiotepa—urinary bladder cancer	0.000979	0.00597	CcSEcCtD
Fidaxomicin—Immune system disorder—Cisplatin—urinary bladder cancer	0.000942	0.00575	CcSEcCtD
Fidaxomicin—Nervous system disorder—Thiotepa—urinary bladder cancer	0.000926	0.00565	CcSEcCtD
Fidaxomicin—Skin disorder—Thiotepa—urinary bladder cancer	0.000918	0.0056	CcSEcCtD
Fidaxomicin—Malnutrition—Cisplatin—urinary bladder cancer	0.000908	0.00554	CcSEcCtD
Fidaxomicin—Anaemia—Gemcitabine—urinary bladder cancer	0.0009	0.00549	CcSEcCtD
Fidaxomicin—Flatulence—Cisplatin—urinary bladder cancer	0.000894	0.00546	CcSEcCtD
Fidaxomicin—Anaemia—Fluorouracil—urinary bladder cancer	0.000885	0.0054	CcSEcCtD
Fidaxomicin—Immune system disorder—Etoposide—urinary bladder cancer	0.000863	0.00526	CcSEcCtD
Fidaxomicin—Anaemia—Cisplatin—urinary bladder cancer	0.000839	0.00512	CcSEcCtD
Fidaxomicin—Dyspepsia—Thiotepa—urinary bladder cancer	0.000832	0.00507	CcSEcCtD
Fidaxomicin—Unspecified disorder of skin and subcutaneous tissue—Gemcitabine—urinary bladder cancer	0.000823	0.00502	CcSEcCtD
Fidaxomicin—Decreased appetite—Thiotepa—urinary bladder cancer	0.000821	0.00501	CcSEcCtD
Fidaxomicin—Gastrointestinal disorder—Thiotepa—urinary bladder cancer	0.000816	0.00498	CcSEcCtD
Fidaxomicin—Dysgeusia—Etoposide—urinary bladder cancer	0.000814	0.00497	CcSEcCtD
Fidaxomicin—Constipation—Thiotepa—urinary bladder cancer	0.000808	0.00493	CcSEcCtD
Fidaxomicin—Nervous system disorder—Gemcitabine—urinary bladder cancer	0.000779	0.00476	CcSEcCtD
Fidaxomicin—Gastrointestinal haemorrhage—Epirubicin—urinary bladder cancer	0.000774	0.00472	CcSEcCtD
Fidaxomicin—Gastrointestinal pain—Thiotepa—urinary bladder cancer	0.000772	0.00471	CcSEcCtD
Fidaxomicin—Skin disorder—Gemcitabine—urinary bladder cancer	0.000772	0.00471	CcSEcCtD
Fidaxomicin—Anaemia—Etoposide—urinary bladder cancer	0.000768	0.00469	CcSEcCtD
Fidaxomicin—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—urinary bladder cancer	0.000767	0.00468	CcSEcCtD
Fidaxomicin—Nervous system disorder—Fluorouracil—urinary bladder cancer	0.000766	0.00468	CcSEcCtD
Fidaxomicin—Abdominal pain—Thiotepa—urinary bladder cancer	0.000747	0.00456	CcSEcCtD
Fidaxomicin—Nervous system disorder—Cisplatin—urinary bladder cancer	0.000726	0.00443	CcSEcCtD
Fidaxomicin—Skin disorder—Cisplatin—urinary bladder cancer	0.000719	0.00439	CcSEcCtD
Fidaxomicin—Gastrointestinal haemorrhage—Doxorubicin—urinary bladder cancer	0.000716	0.00437	CcSEcCtD
Fidaxomicin—Dyspnoea—Gemcitabine—urinary bladder cancer	0.000708	0.00432	CcSEcCtD
Fidaxomicin—Unspecified disorder of skin and subcutaneous tissue—Etoposide—urinary bladder cancer	0.000703	0.00429	CcSEcCtD
Fidaxomicin—Dyspnoea—Fluorouracil—urinary bladder cancer	0.000697	0.00425	CcSEcCtD
Fidaxomicin—Hypersensitivity—Thiotepa—urinary bladder cancer	0.000696	0.00425	CcSEcCtD
Fidaxomicin—Decreased appetite—Gemcitabine—urinary bladder cancer	0.000691	0.00422	CcSEcCtD
Fidaxomicin—Dyspepsia—Fluorouracil—urinary bladder cancer	0.000688	0.0042	CcSEcCtD
Fidaxomicin—Gastrointestinal disorder—Gemcitabine—urinary bladder cancer	0.000686	0.00419	CcSEcCtD
Fidaxomicin—Alanine aminotransferase increased—Epirubicin—urinary bladder cancer	0.000683	0.00417	CcSEcCtD
Fidaxomicin—Constipation—Gemcitabine—urinary bladder cancer	0.00068	0.00415	CcSEcCtD
Fidaxomicin—Decreased appetite—Fluorouracil—urinary bladder cancer	0.000679	0.00414	CcSEcCtD
Fidaxomicin—Gastrointestinal disorder—Fluorouracil—urinary bladder cancer	0.000675	0.00412	CcSEcCtD
Fidaxomicin—Abdominal distension—Epirubicin—urinary bladder cancer	0.000673	0.00411	CcSEcCtD
Fidaxomicin—Dysphagia—Epirubicin—urinary bladder cancer	0.000669	0.00408	CcSEcCtD
Fidaxomicin—Neutropenia—Methotrexate—urinary bladder cancer	0.000668	0.00408	CcSEcCtD
Fidaxomicin—Pruritus—Thiotepa—urinary bladder cancer	0.000668	0.00408	CcSEcCtD
Fidaxomicin—Dyspnoea—Cisplatin—urinary bladder cancer	0.00066	0.00403	CcSEcCtD
Fidaxomicin—Skin disorder—Etoposide—urinary bladder cancer	0.000659	0.00402	CcSEcCtD
Fidaxomicin—Decreased appetite—Cisplatin—urinary bladder cancer	0.000644	0.00393	CcSEcCtD
Fidaxomicin—Gastrointestinal disorder—Cisplatin—urinary bladder cancer	0.000639	0.0039	CcSEcCtD
Fidaxomicin—Alanine aminotransferase increased—Doxorubicin—urinary bladder cancer	0.000632	0.00385	CcSEcCtD
Fidaxomicin—Neutropenia—Epirubicin—urinary bladder cancer	0.000625	0.00382	CcSEcCtD
Fidaxomicin—Dizziness—Thiotepa—urinary bladder cancer	0.000625	0.00381	CcSEcCtD
Fidaxomicin—Abdominal distension—Doxorubicin—urinary bladder cancer	0.000623	0.0038	CcSEcCtD
Fidaxomicin—Dysphagia—Doxorubicin—urinary bladder cancer	0.000619	0.00378	CcSEcCtD
Fidaxomicin—Dyspnoea—Etoposide—urinary bladder cancer	0.000605	0.00369	CcSEcCtD
Fidaxomicin—Hyperglycaemia—Epirubicin—urinary bladder cancer	0.000603	0.00368	CcSEcCtD
Fidaxomicin—Hepatobiliary disease—Methotrexate—urinary bladder cancer	0.000603	0.00368	CcSEcCtD
Fidaxomicin—Vomiting—Thiotepa—urinary bladder cancer	0.000601	0.00367	CcSEcCtD
Fidaxomicin—Rash—Thiotepa—urinary bladder cancer	0.000596	0.00363	CcSEcCtD
Fidaxomicin—Dermatitis—Thiotepa—urinary bladder cancer	0.000595	0.00363	CcSEcCtD
Fidaxomicin—Headache—Thiotepa—urinary bladder cancer	0.000592	0.00361	CcSEcCtD
Fidaxomicin—Decreased appetite—Etoposide—urinary bladder cancer	0.00059	0.0036	CcSEcCtD
Fidaxomicin—Gastrointestinal disorder—Etoposide—urinary bladder cancer	0.000586	0.00357	CcSEcCtD
Fidaxomicin—Constipation—Etoposide—urinary bladder cancer	0.00058	0.00354	CcSEcCtD
Fidaxomicin—Neutropenia—Doxorubicin—urinary bladder cancer	0.000579	0.00353	CcSEcCtD
Fidaxomicin—Hypersensitivity—Fluorouracil—urinary bladder cancer	0.000576	0.00351	CcSEcCtD
Fidaxomicin—Hepatobiliary disease—Epirubicin—urinary bladder cancer	0.000564	0.00344	CcSEcCtD
Fidaxomicin—Pruritus—Gemcitabine—urinary bladder cancer	0.000562	0.00343	CcSEcCtD
Fidaxomicin—Nausea—Thiotepa—urinary bladder cancer	0.000561	0.00342	CcSEcCtD
Fidaxomicin—Hyperglycaemia—Doxorubicin—urinary bladder cancer	0.000558	0.00341	CcSEcCtD
Fidaxomicin—Gastrointestinal pain—Etoposide—urinary bladder cancer	0.000555	0.00339	CcSEcCtD
Fidaxomicin—Pruritus—Fluorouracil—urinary bladder cancer	0.000553	0.00337	CcSEcCtD
Fidaxomicin—Hypersensitivity—Cisplatin—urinary bladder cancer	0.000546	0.00333	CcSEcCtD
Fidaxomicin—Abdominal pain—Etoposide—urinary bladder cancer	0.000536	0.00327	CcSEcCtD
Fidaxomicin—Hepatobiliary disease—Doxorubicin—urinary bladder cancer	0.000522	0.00318	CcSEcCtD
Fidaxomicin—Immune system disorder—Methotrexate—urinary bladder cancer	0.000517	0.00315	CcSEcCtD
Fidaxomicin—Dizziness—Fluorouracil—urinary bladder cancer	0.000517	0.00315	CcSEcCtD
Fidaxomicin—Vomiting—Gemcitabine—urinary bladder cancer	0.000505	0.00308	CcSEcCtD
Fidaxomicin—Rash—Gemcitabine—urinary bladder cancer	0.000501	0.00306	CcSEcCtD
Fidaxomicin—Dermatitis—Gemcitabine—urinary bladder cancer	0.000501	0.00305	CcSEcCtD
Fidaxomicin—Hypersensitivity—Etoposide—urinary bladder cancer	0.0005	0.00305	CcSEcCtD
Fidaxomicin—Malnutrition—Methotrexate—urinary bladder cancer	0.000498	0.00304	CcSEcCtD
Fidaxomicin—Headache—Gemcitabine—urinary bladder cancer	0.000498	0.00304	CcSEcCtD
Fidaxomicin—Vomiting—Fluorouracil—urinary bladder cancer	0.000497	0.00303	CcSEcCtD
Fidaxomicin—Rash—Fluorouracil—urinary bladder cancer	0.000493	0.00301	CcSEcCtD
Fidaxomicin—Dermatitis—Fluorouracil—urinary bladder cancer	0.000492	0.003	CcSEcCtD
Fidaxomicin—Headache—Fluorouracil—urinary bladder cancer	0.000489	0.00299	CcSEcCtD
Fidaxomicin—Dysgeusia—Methotrexate—urinary bladder cancer	0.000488	0.00298	CcSEcCtD
Fidaxomicin—Immune system disorder—Epirubicin—urinary bladder cancer	0.000484	0.00295	CcSEcCtD
Fidaxomicin—Pruritus—Etoposide—urinary bladder cancer	0.00048	0.00293	CcSEcCtD
Fidaxomicin—Nausea—Gemcitabine—urinary bladder cancer	0.000472	0.00288	CcSEcCtD
Fidaxomicin—Vomiting—Cisplatin—urinary bladder cancer	0.000471	0.00287	CcSEcCtD
Fidaxomicin—Rash—Cisplatin—urinary bladder cancer	0.000467	0.00285	CcSEcCtD
Fidaxomicin—Dermatitis—Cisplatin—urinary bladder cancer	0.000467	0.00285	CcSEcCtD
Fidaxomicin—Malnutrition—Epirubicin—urinary bladder cancer	0.000466	0.00284	CcSEcCtD
Fidaxomicin—Nausea—Fluorouracil—urinary bladder cancer	0.000464	0.00283	CcSEcCtD
Fidaxomicin—Anaemia—Methotrexate—urinary bladder cancer	0.00046	0.00281	CcSEcCtD
Fidaxomicin—Flatulence—Epirubicin—urinary bladder cancer	0.000459	0.0028	CcSEcCtD
Fidaxomicin—Dysgeusia—Epirubicin—urinary bladder cancer	0.000456	0.00279	CcSEcCtD
Fidaxomicin—Dizziness—Etoposide—urinary bladder cancer	0.000449	0.00274	CcSEcCtD
Fidaxomicin—Immune system disorder—Doxorubicin—urinary bladder cancer	0.000447	0.00273	CcSEcCtD
Fidaxomicin—Nausea—Cisplatin—urinary bladder cancer	0.00044	0.00268	CcSEcCtD
Fidaxomicin—Vomiting—Etoposide—urinary bladder cancer	0.000431	0.00263	CcSEcCtD
Fidaxomicin—Malnutrition—Doxorubicin—urinary bladder cancer	0.000431	0.00263	CcSEcCtD
Fidaxomicin—Anaemia—Epirubicin—urinary bladder cancer	0.000431	0.00263	CcSEcCtD
Fidaxomicin—Rash—Etoposide—urinary bladder cancer	0.000428	0.00261	CcSEcCtD
Fidaxomicin—Dermatitis—Etoposide—urinary bladder cancer	0.000427	0.00261	CcSEcCtD
Fidaxomicin—Headache—Etoposide—urinary bladder cancer	0.000425	0.00259	CcSEcCtD
Fidaxomicin—Flatulence—Doxorubicin—urinary bladder cancer	0.000425	0.00259	CcSEcCtD
Fidaxomicin—Dysgeusia—Doxorubicin—urinary bladder cancer	0.000422	0.00258	CcSEcCtD
Fidaxomicin—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—urinary bladder cancer	0.000421	0.00257	CcSEcCtD
Fidaxomicin—Nausea—Etoposide—urinary bladder cancer	0.000403	0.00246	CcSEcCtD
Fidaxomicin—Nervous system disorder—Methotrexate—urinary bladder cancer	0.000399	0.00243	CcSEcCtD
Fidaxomicin—Anaemia—Doxorubicin—urinary bladder cancer	0.000399	0.00243	CcSEcCtD
Fidaxomicin—Skin disorder—Methotrexate—urinary bladder cancer	0.000395	0.00241	CcSEcCtD
Fidaxomicin—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—urinary bladder cancer	0.000394	0.0024	CcSEcCtD
Fidaxomicin—Dry mouth—Epirubicin—urinary bladder cancer	0.000388	0.00237	CcSEcCtD
Fidaxomicin—Nervous system disorder—Epirubicin—urinary bladder cancer	0.000373	0.00228	CcSEcCtD
Fidaxomicin—Skin disorder—Epirubicin—urinary bladder cancer	0.000369	0.00225	CcSEcCtD
Fidaxomicin—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—urinary bladder cancer	0.000365	0.00222	CcSEcCtD
Fidaxomicin—Dyspnoea—Methotrexate—urinary bladder cancer	0.000362	0.00221	CcSEcCtD
Fidaxomicin—Dry mouth—Doxorubicin—urinary bladder cancer	0.000359	0.00219	CcSEcCtD
Fidaxomicin—Dyspepsia—Methotrexate—urinary bladder cancer	0.000358	0.00218	CcSEcCtD
Fidaxomicin—Decreased appetite—Methotrexate—urinary bladder cancer	0.000353	0.00216	CcSEcCtD
Fidaxomicin—Gastrointestinal disorder—Methotrexate—urinary bladder cancer	0.000351	0.00214	CcSEcCtD
Fidaxomicin—Nervous system disorder—Doxorubicin—urinary bladder cancer	0.000345	0.00211	CcSEcCtD
Fidaxomicin—Skin disorder—Doxorubicin—urinary bladder cancer	0.000342	0.00209	CcSEcCtD
Fidaxomicin—Dyspnoea—Epirubicin—urinary bladder cancer	0.000339	0.00207	CcSEcCtD
Fidaxomicin—Dyspepsia—Epirubicin—urinary bladder cancer	0.000335	0.00204	CcSEcCtD
Fidaxomicin—Gastrointestinal pain—Methotrexate—urinary bladder cancer	0.000332	0.00203	CcSEcCtD
Fidaxomicin—Decreased appetite—Epirubicin—urinary bladder cancer	0.000331	0.00202	CcSEcCtD
Fidaxomicin—Gastrointestinal disorder—Epirubicin—urinary bladder cancer	0.000328	0.002	CcSEcCtD
Fidaxomicin—Constipation—Epirubicin—urinary bladder cancer	0.000325	0.00198	CcSEcCtD
Fidaxomicin—Abdominal pain—Methotrexate—urinary bladder cancer	0.000321	0.00196	CcSEcCtD
Fidaxomicin—Dyspnoea—Doxorubicin—urinary bladder cancer	0.000314	0.00191	CcSEcCtD
Fidaxomicin—Gastrointestinal pain—Epirubicin—urinary bladder cancer	0.000311	0.0019	CcSEcCtD
Fidaxomicin—Dyspepsia—Doxorubicin—urinary bladder cancer	0.00031	0.00189	CcSEcCtD
Fidaxomicin—Decreased appetite—Doxorubicin—urinary bladder cancer	0.000306	0.00187	CcSEcCtD
Fidaxomicin—Gastrointestinal disorder—Doxorubicin—urinary bladder cancer	0.000304	0.00185	CcSEcCtD
Fidaxomicin—Constipation—Doxorubicin—urinary bladder cancer	0.000301	0.00184	CcSEcCtD
Fidaxomicin—Abdominal pain—Epirubicin—urinary bladder cancer	0.000301	0.00183	CcSEcCtD
Fidaxomicin—Hypersensitivity—Methotrexate—urinary bladder cancer	0.000299	0.00183	CcSEcCtD
Fidaxomicin—Gastrointestinal pain—Doxorubicin—urinary bladder cancer	0.000288	0.00176	CcSEcCtD
Fidaxomicin—Pruritus—Methotrexate—urinary bladder cancer	0.000288	0.00175	CcSEcCtD
Fidaxomicin—Hypersensitivity—Epirubicin—urinary bladder cancer	0.00028	0.00171	CcSEcCtD
Fidaxomicin—Abdominal pain—Doxorubicin—urinary bladder cancer	0.000278	0.0017	CcSEcCtD
Fidaxomicin—Pruritus—Epirubicin—urinary bladder cancer	0.000269	0.00164	CcSEcCtD
Fidaxomicin—Dizziness—Methotrexate—urinary bladder cancer	0.000269	0.00164	CcSEcCtD
Fidaxomicin—Hypersensitivity—Doxorubicin—urinary bladder cancer	0.000259	0.00158	CcSEcCtD
Fidaxomicin—Vomiting—Methotrexate—urinary bladder cancer	0.000258	0.00158	CcSEcCtD
Fidaxomicin—Rash—Methotrexate—urinary bladder cancer	0.000256	0.00156	CcSEcCtD
Fidaxomicin—Dermatitis—Methotrexate—urinary bladder cancer	0.000256	0.00156	CcSEcCtD
Fidaxomicin—Headache—Methotrexate—urinary bladder cancer	0.000255	0.00155	CcSEcCtD
Fidaxomicin—Dizziness—Epirubicin—urinary bladder cancer	0.000252	0.00153	CcSEcCtD
Fidaxomicin—Pruritus—Doxorubicin—urinary bladder cancer	0.000249	0.00152	CcSEcCtD
Fidaxomicin—Vomiting—Epirubicin—urinary bladder cancer	0.000242	0.00148	CcSEcCtD
Fidaxomicin—Nausea—Methotrexate—urinary bladder cancer	0.000241	0.00147	CcSEcCtD
Fidaxomicin—Rash—Epirubicin—urinary bladder cancer	0.00024	0.00146	CcSEcCtD
Fidaxomicin—Dermatitis—Epirubicin—urinary bladder cancer	0.00024	0.00146	CcSEcCtD
Fidaxomicin—Headache—Epirubicin—urinary bladder cancer	0.000238	0.00145	CcSEcCtD
Fidaxomicin—Dizziness—Doxorubicin—urinary bladder cancer	0.000233	0.00142	CcSEcCtD
Fidaxomicin—Nausea—Epirubicin—urinary bladder cancer	0.000226	0.00138	CcSEcCtD
Fidaxomicin—Vomiting—Doxorubicin—urinary bladder cancer	0.000224	0.00137	CcSEcCtD
Fidaxomicin—Rash—Doxorubicin—urinary bladder cancer	0.000222	0.00135	CcSEcCtD
Fidaxomicin—Dermatitis—Doxorubicin—urinary bladder cancer	0.000222	0.00135	CcSEcCtD
Fidaxomicin—Headache—Doxorubicin—urinary bladder cancer	0.00022	0.00135	CcSEcCtD
Fidaxomicin—Nausea—Doxorubicin—urinary bladder cancer	0.000209	0.00128	CcSEcCtD
